Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129683) titled 'Effects of Bifidobacterium longum subsp. longum BLG-19 on Skin Barrier and Hydration in Healthy Adults' on Aug. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Fengxian District Central Hospital
Condition:
Participants shall be aged >=18 and <=60 years of either gender, and be healthy individuals with dry skin and impaired skin barrier function.
Intervention:
Test group:Oral administration of Bifidobacterium longum subsp. longum BLG-19, one sachet once daily. Take directly or dissolve in 100 mL warm water (water temperature <= 40degC) for oral intake.
Recruitment Stat...